IWC
HRTX icon

Integrated Wealth Concepts’s Heron Therapeutics HRTX Stock Holding History

Integrated Wealth Concepts’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76.4K Buy
95,498
+324
+0.3% +$375 ﹤0.01% 2197
2025
Q4 		$124K Sell
95,174
-2,421
-2% -$2.99K ﹤0.01% 1555
2025
Q3 		$123K Buy
97,595
+3,190
+3% +$5.06K ﹤0.01% 1904
2025
Q2 		$195K Buy
94,405
+100
+0.1% +$204 ﹤0.01% 1776
2025
Q1 		$207K Sell
94,305
-16,778
-15% -$32.6K ﹤0.01% 1603
2024
Q4 		$170K Buy
111,083
+62,305
+128% +$101K ﹤0.01% 1628
2024
Q3 		$97.1K Sell
48,778
-2,000
-4% -$4.78K ﹤0.01% 1611
2024
Q2 		$178K Buy
50,778
+2,000
+4% +$6.14K ﹤0.01% 1539
2024
Q1 		$135K Buy
48,778
+16,778
+52% +$42.2K ﹤0.01% 1563
2023
Q4 		$54.4K Buy
+32,000
New +$35.2K ﹤0.01% 1556

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Integrated Wealth Concepts's HRTX Position: Q1 2026 in Review

Integrated Wealth Concepts increased its Heron Therapeutics (HRTX) stake by 0.34% in Q1 2026, buying an estimated $375 and bringing the position to 95,498 shares worth $76.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2197.

Integrated Wealth Concepts first reported a position in HRTX in Q4 2023 and has held it in 10 quarters since. The position peaked at $207K in Q1 2025. 167 funds tracked by Wall St. Rank hold HRTX as of Q1 2026.

  • Integrated Wealth Concepts held 95,498 shares of Heron Therapeutics worth $76.4K as of Q1 2026.
  • Integrated Wealth Concepts bought 324 Heron Therapeutics shares in Q1 2026, an estimated $375.
  • Heron Therapeutics made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q1 2026, its #2197 holding.
  • Integrated Wealth Concepts first reported a position in Heron Therapeutics in Q4 2023 and has held it in 10 quarters since.
  • Integrated Wealth Concepts's Heron Therapeutics position peaked at $207K in Q1 2025.
  • 167 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2026.

Based on Integrated Wealth Concepts's 13F filing for Q1 2026, filed 15 May 2026.